|
Market Closed -
Bombay S.E.
06:02:36 2026-10-28 EDT
|
5-day change | 1st Jan Change | ||
| 1,971.00 INR | +0.61% |
|
+0.72% | -6.68% |
| 10-25 | Lupin's Goa Facility Receives One Observation in US FDA Inspection | MT |
| 10-23 | Lupin Appoints Chief Legal Officer | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 9.43B | |||||
| 1,143B | |||||
| 647B | |||||
| 506B | |||||
| 384B | |||||
| 350B |
- Stock Market
- Stocks
- LUPIN Stock
- Charts Lupin Limited
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
